[Clinical manifestation and chemotherapy in Hodgkin's disease].
D002699:Chlorambucil / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D006689:Hodgkin Disease / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D006801:Humans; D007813:Laparotomy; D008722:Methods; D008727:Methotrexate / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D011379:Prognosis; D012075:Remission, Spontaneous; D013156:Splenectomy; D013160:Splenic Neoplasms / Q000188:drug therapy / Q000601:surgery; D014747:Vinblastine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D002699:Chlorambucil; D011344:Procarbazine; D014750:Vincristine; D014747:Vinblastine; D003520:Cyclophosphamide; D011241:Prednisone; D008727:Methotrexate
Klinik und chemotherapiee der Lymphogranulomatose.